We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
-13.53%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$236B
AUM Growth
-$73.2B
Cap. Flow
+$2.01B
Cap. Flow %
0.85%
Top 10 Hldgs %
30.43%
Holding
11,601
New
1,426
Increased
3,968
Reduced
4,014
Closed
2,058

Sector Composition

Rank Sector Weight
1 Technology 2.05%
2 Consumer Discretionary 1.68%
3 Financials 1.25%
4 Communication Services 0.95%
5 Energy 0.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIEWW
9126
DELISTED
View, Inc. Warrant
VIEWW
$18K ﹤0.01%
177,286
-473
-0.3% -$84
FRTX
9127
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$18K ﹤0.01%
+3,093
New +$28K
APGB.WS
9128
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$18K ﹤0.01%
71,112
-1,707
-2% -$754
OPAD.WS
9129
DELISTED
Offerpad Solutions Inc. Warrants, Every 15 warrants will be exercisable for one share of Class A Common Stock at an exercise price of $172.50 per share of Class A Common Stock
OPAD.WS
$18K ﹤0.01%
71,952
+1,314
+2% +$812
PRPC.WS
9130
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$18K ﹤0.01%
60,311
-251
-0.4% -$114
GSEVW
9131
DELISTED
Gores Holdings VII, Inc. Warrant
GSEVW
$18K ﹤0.01%
39,721
+59
+0.1% +$37
SCLEW
9132
DELISTED
Broadscale Acquisition Corp. Warrant
SCLEW
$18K ﹤0.01%
75,000
-91
-0.1% -$49
LOGC
9133
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$18K ﹤0.01%
+51,381
New +$26K
AKBA icon
9134
CALL
Akebia Therapeutics
AKBA
$252M
$17K ﹤0.01%
47,300
-116,800
-71% -$49K
DSS icon
9135
DSS Inc
DSS
$5.13M
$17K ﹤0.01%
2,662
+598
+29% +$4.75K
SWAG icon
9136
Stran & Co
SWAG
$36.5M
$17K ﹤0.01%
10,114
-3,022
-23% -$5.48K
TANH icon
9137
Tantech Holdings
TANH
$6.1M
$17K ﹤0.01%
59
+35
+146% +$11.6K
TNXP icon
9138
Tonix Pharmaceuticals
TNXP
$192M
$17K ﹤0.01%
+1
New +$73.8K
SEEL
9139
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$17K ﹤0.01%
6
VIEW
9140
DELISTED
View, Inc. Class A Common Stock
VIEW
$17K ﹤0.01%
176
-3,188
-95% -$284K
SPPI
9141
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$17K ﹤0.01%
21,157
-18,147
-46% -$16K
NDACW
9142
DELISTED
NightDragon Acquisition Corp. Warrants to purchase Class A common stock
NDACW
$17K ﹤0.01%
62,639
+415
+0.7% +$154
PCPC.WS
9143
DELISTED
Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75
PCPC.WS
$17K ﹤0.01%
37,521
+21
+0.1% +$13
EQOS
9144
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$17K ﹤0.01%
20,299
+4,558
+29% +$6.07K
HAACW
9145
DELISTED
Health Assurance Acquisition Corp. Warrants
HAACW
$17K ﹤0.01%
125,012
-2,211
-2% -$707
WMC
9146
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$17K ﹤0.01%
1,428
-4,253
-75% -$57.5K
BARK.WS
9147
DELISTED
BARK Inc Warrants
BARK.WS
$16K ﹤0.01%
84,462
-438
-0.5% -$151
CIFR icon
9148
Cipher Digital
CIFR
$7.13B
$16K ﹤0.01%
12,151
-50,231
-81% -$122K
FURY
9149
Fury Gold Mines
FURY
$114M
$16K ﹤0.01%
+29,915
New +$18.6K
GERN icon
9150
PUT
Geron
GERN
$949M
$16K ﹤0.01%
+10,000
New +$14.1K

Similar funds

Jane Street's Q2 2022 Portfolio in Review

As of Q2 2022, Jane Street held 11,601 positions worth $236B, down 24% from $309B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jane Street's Q2 2022 filing shows 1,426 new, 3,968 increased, 4,014 reduced and 2,058 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 30,902,851 shares worth $1.24B. The largest sale was Vanguard FTSE Europe ETF, an estimated $750M.

By sector, the portfolio is most concentrated in Technology at 2.1% of assets, down from 2.2% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Jane Street's largest Q2 2022 buy was iShares MSCI Emerging Markets ETF: 30,902,851 shares worth $1.24B.
  • Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $1.24B increase.
  • Jane Street's biggest Q2 2022 reduction was Vanguard FTSE Europe ETF, cutting an estimated $750M.
  • Jane Street fully exited iShares MSCI Global Min Vol Factor ETF in Q2 2022, selling an estimated $229M.
  • Jane Street's ten largest holdings make up 30% of its $236B portfolio in Q2 2022.
  • Jane Street opened 1,426 new positions and closed 2,058 in Q2 2022.
  • Jane Street's portfolio value fell 24% quarter-over-quarter to $236B.

Based on Jane Street's 13F filing for Q2 2022, filed 16 Aug 2022.